Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-5,432
Closed -$403K 183
2024
Q2
$403K Buy
+5,432
New +$407K 0.12% 112
2023
Q3
Sell
-3,602
Closed -$292K 190
2023
Q2
$292K Buy
+3,602
New +$294K 0.11% 140

Other funds holding HOLX

Covenant Partners's HOLX Position: Q3 2024 in Review

Covenant Partners sold out of Hologic (HOLX) in Q3 2024, closing a stake of 5,432 shares — an estimated $403K sold.

Covenant Partners first reported a position in HOLX in Q2 2023 and held it in 2 quarters. The position peaked at $403K in Q2 2024. 726 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Covenant Partners reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Covenant Partners sold 5,432 Hologic shares in Q3 2024, an estimated $403K.
  • Covenant Partners first reported a position in Hologic in Q2 2023 and held it in 2 quarters.
  • Covenant Partners's Hologic position peaked at $403K in Q2 2024.
  • 726 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Covenant Partners's 13F filing for Q3 2024, filed 24 Oct 2024.